EICHOR
● Completed
Efficacy, Safety, and Pharmacokinetics of Leuprolide Mesylate in Subjects With Central Precocious Puberty
Condition: Puberty; Precocious, Central · Sponsor: Foresee Pharmaceuticals Co., Ltd.
About this study
The study will evaluate if Leuprolide Mesylate is safe and effective in the treatment of subjects with central (gonadotropin-dependent) precocious puberty, when administered as two injections six months apart.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (41)
| Arizona University | Tucson, Arizona, United States | — |
| Rady Children's Hospital- San Diego | San Diego, California, United States | — |
| Nemours Children's Health Center | Jacksonville, Florida, United States | — |
| Johns Hopkins - All Children's Hospital | St. Petersburg, Florida, United States | — |
| Rocky Mountain Clinical Research | Idaho Falls, Idaho, United States | — |
| Indiana University | Indianapolis, Indiana, United States | — |
| University of Texas Southwestern Medical Center | Dallas, Texas, United States | — |
| Cook Children's | Fort Worth, Texas, United States | — |
| Virginia University | Charlottesville, Virginia, United States | — |
| Multicare Health System | Tacoma, Washington, United States | — |
| The Second Hospital of Anhui Medical University | Hefei, Anhui, China | — |
| Children's Hospital affiliated to Capital Institute of Pediatrics | Beijing, Chaoyang District, China | — |
+ 29 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05493709